Cellular Intelligence Acquires Global Rights To Novo Nordisk’s Clinical-Stage Parkinson’s Cell Therapy Program
Cellular Intelligence has announced an agreement to acquire global rights to Novo Nordisk’s clinical-stage cell therapy program for…